If you see the list I have tried to compile & it should be nearly accurate; it is clear that those who were in the top 10, only 1 remains (Pfizer), rest have merged or sold.

Over the past forty years, pharma has seen an incredible journey. We witnessed the dominance of multinational giants in the 1980s, the rise of Indian companies in the 1990s and 2000s, and the emergence of biotech, generics, and global reach in the decades that followed. Each era brought its own wave of transformation.

Yet, what lies ahead is far bigger. The truth is this: the next four years will change pharma more than the last forty combined. I can say with surety, that every single pharmaceutical company will have to reinvent itself to be in business. Else, the pharma market will replicate what Tesla did to the automobile companies.

Digital Health is not just a buzzword—it is already accelerating drug discovery, optimizing clinical trials, and personalizing patient engagement. Genomics and biomarkers are turning precision medicine into everyday reality. Digital therapeutics are expanding the very definition of treatment. And patients today expect not only innovation, but also access, affordability, and equity—pushing companies and policymakers to reimagine how value is delivered.

This shift is happening at lightning speed. The “blockbuster model” that defined success for decades is giving way to a new ecosystem—one where collaboration across pharma, tech, and policy is the key to survival and growth.

And that is exactly why the Global Digital Health Summit has become the place where the future is being shaped. The leaders driving this transformation—pharma CEOs, innovators, regulators, technologists, and clinicians—will be at one table, debating, sharing, and co-creating what’s next.

If you are part of the pharma space—whether in R&D, manufacturing, marketing, or policy—you cannot afford to sit this one out. This is not just another event; it is a once-in-a-decade opportunity to see where the industry is headed and to ensure you are part of the conversation.

The last forty years built the foundations of pharma. The next four will decide its destiny. Be there when history is being written. Join us: www.globalsummit.health

The companies of the future are yet to be born!

Dr. Rajendra Pratap Gupta, PhD

Summit Co-chair

#pharma #pharmaceuticals #generics #biotech #drugdiscovery Indian Pharmacopoeia Commission Indian Pharmaceutical Association Students Forum AIOCD (All India Organisation of Chemists and Druggists) OPPI India Rajeev Raghuvanshi